学術委員会が選ぶ必読論文005


1)敗血症性ショックに対するエンドトキシン吸着療法 - EUPHRATES trial -
EUPHRATES Trial Investigators, et al. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients with Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial. JAMA. 2018, 320(14) 1455-1463.
2)急性腎障害および敗血症の患者における腎代替療法のタイミング。
Barbar SD, et al. Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis. N Engl J Med. 2018, 379(15) 1431-1442.
3)重篤なAKI患者の血漿バイオマーカによる腎臓回復の予測。
Fiorentino M, et al. Plasma Biomarkers in Predicting Renal Recovery from Acute Kidney Injury in Critically Ill Patients. Blood Purif. 2019, 48(3) 253-261.